Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine.
Ferrer-Montiel AV
,
Sun W
,
Montal M
.
???displayArticle.abstract???
The N-methyl-D-aspartate receptor (NMDAR), a pivotal entity for synaptic plasticity and excitotoxicity in the brain, is a target of psychotomimetic drugs such as phencyclidine (PCP) and dizolcipine (MK-801). In contrast, a related glutamate receptor, the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate/kainate receptor GluR1, is weakly sensitive to these drugs. Three point mutations on GluR1, mimicking homologous residues on the NMDAR, confer the PCP and MK-801 blockade properties that are characteristic of the NMDAR--namely, high potency, voltage dependence, and use dependence. The molecular determinants that specify the PCP block appear confined to the putative M2 transmembrane segment, whereas the sensitivity to MK-801 requires an interplay between residues from M2 and M3. Given the plausible involvement of the NMDAR in the etiology of several neurodegenerative diseases and in excitotoxic neuronal cell death, tailored glutamate receptors with specific properties may be models for designing and screening new drugs targeted to prevent glutamate-mediated neural damage.
Bennett,
Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop.
1995, Pubmed,
Xenbase
Bennett,
Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop.
1995,
Pubmed
,
Xenbase
Burnashev,
Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor.
1992,
Pubmed
,
Xenbase
Choi,
The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death.
1990,
Pubmed
Choi,
Bench to bedside: the glutamate connection.
1992,
Pubmed
Collingridge,
Excitatory amino acid receptors in the vertebrate central nervous system.
1989,
Pubmed
Davies,
Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner.
1988,
Pubmed
Dingledine,
Structural determinants of barium permeation and rectification in non-NMDA glutamate receptor channels.
1992,
Pubmed
,
Xenbase
Durand,
Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C.
1992,
Pubmed
,
Xenbase
Ferrer-Montiel,
A negative charge in the M2 transmembrane segment of the neuronal alpha 7 acetylcholine receptor increases permeability to divalent cations.
1993,
Pubmed
,
Xenbase
Foster,
Therapeutic potential of NMDA receptor antagonists as neuroprotective agents.
1990,
Pubmed
Galzi,
Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic.
1992,
Pubmed
,
Xenbase
Hollmann,
Cloned glutamate receptors.
1994,
Pubmed
Hollmann,
N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1.
1994,
Pubmed
,
Xenbase
Honey,
Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid.
1985,
Pubmed
Huettner,
Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels.
1988,
Pubmed
Ishii,
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.
1993,
Pubmed
,
Xenbase
Kozikowski,
Structural determinants of affinity for the phencyclidine binding site of the N-methyl-D-aspartate receptor complex: discovery of a rigid phencyclidine analogue of high binding affinity.
1990,
Pubmed
Kunkel,
Rapid and efficient site-specific mutagenesis without phenotypic selection.
1987,
Pubmed
Laemmli,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
1970,
Pubmed
Leeson,
Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel.
1990,
Pubmed
Lerma,
Interaction of Mg2+ and phencyclidine in use-dependent block of NMDA channels.
1991,
Pubmed
,
Xenbase
MacDonald,
Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones.
1991,
Pubmed
Manallack,
Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
1988,
Pubmed
Masu,
Molecular characterization of NMDA and metabotropic glutamate receptors.
1993,
Pubmed
Mishina,
Molecular and functional diversity of the NMDA receptor channel.
1993,
Pubmed
Monyer,
Heteromeric NMDA receptors: molecular and functional distinction of subtypes.
1992,
Pubmed
Moriyoshi,
Molecular cloning and characterization of the rat NMDA receptor.
1991,
Pubmed
,
Xenbase
Nakanishi,
Molecular diversity of glutamate receptors and implications for brain function.
1992,
Pubmed
Nakanishi,
Molecular diversity and functions of glutamate receptors.
1994,
Pubmed
Olney,
Excitotoxic amino acids and neuropsychiatric disorders.
1990,
Pubmed
Sakurada,
Alteration of Ca2+ permeability and sensitivity to Mg2+ and channel blockers by a single amino acid substitution in the N-methyl-D-aspartate receptor.
1993,
Pubmed
,
Xenbase
Sun,
Molecular cloning, chromosomal mapping, and functional expression of human brain glutamate receptors.
1992,
Pubmed
,
Xenbase
Unwin,
Neurotransmitter action: opening of ligand-gated ion channels.
1993,
Pubmed
Wo,
Transmembrane topology of two kainate receptor subunits revealed by N-glycosylation.
1994,
Pubmed
Wong,
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
1986,
Pubmed
Yamakura,
Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists.
1993,
Pubmed
,
Xenbase
